Cancer Research UK launches trial to test new drug
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK...
List view / Grid view
News
FDA evaluates prescription opioid medications approved for children
The FDA has heard from professional groups, including the American Academy of Paediatrics about the use of opioid cough suppressants for children...
Lab Innovations continues its successful partnership with the Royal Society of Chemistry
Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – returns to the NEC, Birmingham, for its sixth consecutive year on the 1st and 2nd of November 2017...
Superbug squashed by super-team of antibiotics
Researchers have found that a novel combination of antibiotics that was able to kill E. coli carrying mcr-1 and ndm-5 genes within 24 hours...
Biochemical fingerprints reveal diabetes progression
Researchers have described a new method to study biochemical changes that occur in the pancreas during the development of diabetes...
Lasers used to detect risk of heart attack and stroke
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light...
Venture launched for a novel compound against malaria
A patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite has been launched...
FDA grants approval of Besponsa for acute lymphoblastic leukaemia
The FDA has approved Besponsa for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia...
FDA grants two orphan drug designations for HCC
The FDA has granted two orphan drug designations for T cell therapy products for the treatment of hepatocellular carcinoma...
Latency of seizures determined by diet
Researchers have connected docosahexaenoic (DHA) synthesis to oestrogen production and consequentially brain health...
Using native mass spectrometry for drug development
Mass spectrometry (MS) performed under native-like conditions (nMS) is a promising approach for studying protein-drug interactions, and has already informed treatments of some of the most intractable diseases including cancer, diabetes and Alzheimer’s.
Multicolour MRIs could aid disease detection
Researchers have developed a method that could make magnetic resonance imaging (MRI) multicoloured - a strategy that could serve as a research tool and even aid disease diagnosis...
Machine-learning program shows promise for Alzheimer’s diagnosis
Researchers have developed a new machine-learning program that appears to outperform other methods for diagnosing Alzheimer’s disease...
Accelerated drugs approval evaluated
Researchers have evaluate the features of pre-approval and post-approval clinical trials of drugs granted Accelerated Approval by the FDA...
New imaging technique may predict the spread of breast cancer
Researchers have developed a new imaging technique to detect myeloid-derived suppressor cells’ accumulating in the lung...
